|
Code |
Kit |
Description |
N. test |
|
Amplikit MTHFR C677T |
|
0503 |
Methylenetetrahydrofolate reductase (MTHFR),
677 C/T
Applications: Atherosclerosis, arterial
and venous thrombosis, obstetrics
complications |
Amplification of human genomic DNA
region surrounding the position 677 of
the methylenetetrahydrofolate reductase
gene, and subsequent restriction
fragments length polymorphism analysis |
50 |
|
Amplikit PRT |
|
0502 |
Coagulation factor II (prothrombin),
20210 G/A
Applications: Venous and arterial
thrombosis, obstetrics complications |
Amplification of human genomic DNA
region surrounding the position 20210 of
the factor II gene, and subsequent
restriction fragments length
polymorphism analysis |
50 |
|
Amplikit FVL |
|
0501 |
Coagulation factor V, 1691 G/A (FV
Leiden)
Applications: Venous thrombosis,
obstetrics complications, arterial
thrombosis at young age |
Amplification of human genomic DNA
region surrounding the position 1691 of
the factor V gene, and subsequent
restriction fragments length
polymorphism analysis |
50 |
|
AmpliKit Gilbert's syndrome (A(TA)6TAA/A
(TA)7TAA)
 |
|
010723 |
UGT1A1 A(TA)6TAA/A (TA)7TAA |
Amplification with sequence-specific
primers |
50 |
|
AmpliKit Cystic Fibrosis Asn1303Lys
 |
|
010717 |
CFTR Asn1303Lys |
Amplification with sequence-specific
primers |
50 |
|
AmpliKit Cystic Fibrosis Trp1282Ter
 |
|
010716 |
CFTR Trp1282Ter |
Amplification with sequence-specific
primers |
50 |
|
AmpliKit Cystic Fibrosis Gly551Asp
 |
|
010715 |
CFTR Gly551Asp |
Amplification with sequence-specific
primers |
50 |
|
AmpliKit Cystic Fibrosis Gly542Ter
 |
|
010714 |
CFTR Gly542Ter |
Amplification with sequence-specific
primers |
50 |
|
AmpliKit Cystic Fibrosis Phe508Del
 |
|
010713 |
CFTR Phe508Del |
Amplification with sequence-specific
primers |
50 |
|
AmpliKit ATPase, Cu++ transporting, beta
polypeptide Gly1267Arg (Wilson disease)
 |
|
010722 |
ATP7B Gly1267Arg |
Amplification with sequence-specific
primers |
50 |
|
AmpliKit ATPase, Cu++ transporting, beta
polypeptide del C3402 (Wilson disease)
 |
|
010721 |
ATP7B del C3402 |
Amplification with sequence-specific
primers |
50 |
|
AmpliKit ATPase, Cu++ transporting, beta
polypeptide His1069Gln (Wilson disease)
 |
|
010712 |
ATP7B His1069Gln |
Amplification with sequence-specific
primers |
50 |
|
AmpliKit Aldehyde dehydrogenase ALDH2
 |
|
010709 |
ALDH2 Glu487Lys (ALDH2*2) |
Amplification with sequence-specific
primers |
50 |
|
AmpliKit Alcohol dehydrogenase ADH1B
 |
|
010708 |
ADH1B Arg47His (ADH2*1/ADH2*2) |
Amplification with sequence-specific
primers |
50 |
|
AmpliKit FVII Arg353Gln
 |
|
010704 |
FVII Arg353Gln |
Amplification with sequence-specific
primers |
50 |
|
Amplikit ENOS
 |
|
0601 |
Endothelial Nitric Oxide Synthase eNOS
786 T/C
Applications: Hypertension,
atherosclerosis, venous and arterial
thrombosis, obstetrics complications |
PCR mediated amplification of human
genomic DNA region surrounding the
position “–786” of the nitric oxide
endothelial synthetase (eNOS) gene, and
subsequent restriction fragments length
polymorphism analysis (PCR-RFLP) |
50 |
|
Amplikit MTHFD1
 |
|
0602 |
Methylenetetrahydrofolate dehydrogenase
(MTHFD1), 1958 G/A
Applications: Therapeutic response to
antifolate chemotherapeutics in acute
lymphoblastic leukemia, risk of
pregnancy loss, risk of neural tube
defect, risk of abruptio placentae,
atherosclerosis, venous and arterial
thrombosis |
PCR mediated amplification of human
genomic DNA region surrounding the
position 1958 of the MTHFD1 gene, and
subsequent restriction fragments length
polymorphism analysis (PCR-RFLP) |
50 |
|
Amplikit ESTR
 |
|
0603 |
Estrogen receptor (ER-α), IVS-1- 397T/C
Applications: Myocardial infarction,
intracerebral hemorrhage, osteoporosis,
breast cancer, neurodegenerative
diseases |
PCR mediated amplification of human
genomic DNA region surrounding the
position –397 of the ER-α gene intron 1
(IVS-1), and subsequent restriction
fragments length polymorphism analysis (PCR-RFLP) |
50 |
|
Amplikit VDRF
 |
|
0604 |
Vitamine D receptor D (VDR), start codon
F/f
Applications: Osteoporosis,
tuberculosis, prostate cancer, breast
cancer, urolithiasis |
PCR mediated amplification of human
genomic DNA region surrounding start
codon of the vitamin D receptor (VDR)
gene, and subsequent restriction
fragments length polymorphism analysis (PCR-RFLP) |
50 |
|
Amplikit GPIA |
|
0505 |
Glycoprotein Ia (GpIa), 807 C/T
Applications: Atherosclerosis, arterial
and venous thrombosis, obstetrics
complications |
Amplification of human genomic DNA
region surrounding the position 807 of
the glycoprotein Ia gene, and subsequent
restriction fragments length
polymorphism analysis |
50 |
|
Amplikit HPA-1 |
|
0506 |
Glycoprotein IIIa (GpIIIa), 1565 T/C
(PIA1/A2)
Applications: Arterial and venous
thrombosis, obstetrics complications,
platelet transfusions |
Amplification of human genomic DNA
region surrounding the position 1565 of
the glycoprotein IIIa gene, and
subsequent restriction fragments length
polymorphism analysis |
50 |
|
Amplikit HPA-2 |
|
0507 |
Glycoprotein Ibα (GpIbα), 434 C/T
(Thr145Met)
Applications: Arterial and venous
thrombosis, obstetrics complications,
platelet transfusions |
Amplification of human genomic DNA
region surrounding the position 434 of
the glycoprotein Ibα gene, and
subsequent restriction fragments length
polymorphism analysis |
50 |
|
Amplikit HPA-3 |
|
0509 |
Glycoprotein IIb (GpIIb), 843 IIe/Ser
Applications: platelet transfusions
|
Amplification of human genomic DNA
region surrounding the position 843 of
the glycoprotein IIb, and subsequent
restriction fragments length
polymorphism analysis |
50 |
|
Amplikit PAI-1 |
|
0511 |
Plasminogen activator inhibitor type I,
-675 4G/5G
Applications: Arterial and venous
thrombosis, obstetrics complications
|
Amplification of human genomic DNA
region surrounding the position 675 and
subsequent restriction fragments length
polymorphism analysis |
50 |
<